210 related articles for article (PubMed ID: 34249474)
1. A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1.
Shah D; Comba A; Faisal SM; Kadiyala P; Baker GJ; Alghamri MS; Doherty R; Zamler D; Nuñez G; Castro MG; Lowenstein PR
Oncoimmunology; 2021; 10(1):1939601. PubMed ID: 34249474
[TBL] [Abstract][Full Text] [Related]
2. Absence of Mal/TIRAP Results in Abrogated Imidazoquinolinones-Dependent Activation of IRF7 and Suppressed IFNβ and IFN-I Activated Gene Production.
Leszczyńska E; Makuch E; Mitkiewicz M; Jasyk I; Narita M; Górska S; Lipiński T; Siednienko J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255528
[TBL] [Abstract][Full Text] [Related]
3. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Derkow K; Bauer JM; Hecker M; Paap BK; Thamilarasan M; Koczan D; Schott E; Deuschle K; Bellmann-Strobl J; Paul F; Zettl UK; Ruprecht K; Lehnardt S
PLoS One; 2013; 8(8):e70626. PubMed ID: 23950974
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation
Stegemann-Koniszewski S; Behrens S; Boehme JD; Hochnadel I; Riese P; Guzmán CA; Kröger A; Schreiber J; Gunzer M; Bruder D
Front Immunol; 2018; 9():245. PubMed ID: 29497422
[TBL] [Abstract][Full Text] [Related]
6. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
7. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.
Schoenemeyer A; Barnes BJ; Mancl ME; Latz E; Goutagny N; Pitha PM; Fitzgerald KA; Golenbock DT
J Biol Chem; 2005 Apr; 280(17):17005-12. PubMed ID: 15695821
[TBL] [Abstract][Full Text] [Related]
8. TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.
Kim H; Khanna V; Kucaba TA; Zhang W; Sehgal D; Ferguson DM; Griffith TS; Panyam J
Mol Pharm; 2020 Jun; 17(6):2109-2124. PubMed ID: 32383885
[TBL] [Abstract][Full Text] [Related]
9. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
10. Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.
Toka FN; Nfon CK; Dawson H; Golde WT
Clin Vaccine Immunol; 2009 Jun; 16(6):866-78. PubMed ID: 19369481
[TBL] [Abstract][Full Text] [Related]
11. Human Metapneumovirus M2-2 Protein Acts as a Negative Regulator of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Kitagawa Y; Sakai M; Funayama M; Itoh M; Gotoh B
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768858
[TBL] [Abstract][Full Text] [Related]
12. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.
Baker GJ; Chockley P; Yadav VN; Doherty R; Ritt M; Sivaramakrishnan S; Castro MG; Lowenstein PR
Cancer Res; 2014 Sep; 74(18):5079-90. PubMed ID: 25038230
[TBL] [Abstract][Full Text] [Related]
14. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
[TBL] [Abstract][Full Text] [Related]
16. The TIR-domain containing adaptor TRAM is required for TLR7 mediated RANTES production.
Shevlin E; Miggin SM
PLoS One; 2014; 9(9):e107141. PubMed ID: 25211222
[TBL] [Abstract][Full Text] [Related]
17. MEKK3 activates IRF7 to trigger a potent type I interferon induction in response to TLR7/9 signaling.
Cai M; Huang W; Hu X; Chen A; Zhou X
Mol Immunol; 2021 Jun; 134():183-191. PubMed ID: 33812250
[TBL] [Abstract][Full Text] [Related]
18. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
[TBL] [Abstract][Full Text] [Related]
19. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
20. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
Dhariwala MO; Olson RM; Anderson DM
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
